SEARCH

SEARCH BY CITATION

Bibliography

  • 1
    Poupon RE, Poupon R & Balkau B. and the UDCA-PBC Group. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994; 330: 13427.
  • 2
    Heathcote EJ, Cauch-dudek K & Walker V, et al. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994; 19: 114956.
  • 3
    Lindor KD, Dickson ER & Baldus WP, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994; 106: 128490.
  • 4
    Combes B, Carithers RL, Maddrey WC, Lin D, McDonald MF & Wheeeler DE. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1995; 22: 75966.
  • 5
    Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M & Dickson ER. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology 1996; 110: 15158.
  • 6
    Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R & Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997; 113: 88490.
  • 7
    Goulis J, Leandro G & Burroughs AK. Randomized controlled trials of ursodeoxycholic acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet 1999; 354: 105360.DOI: 10.1016/s0140-6736(98)11293-x
  • 8
    Floreani A, Zappalà F, Mazzetto M, Naccarato R, Plebani M & Chiaramonte M. Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease. Dig Dis Sci 1994; 1: 914.
  • 9
    Kaplan MM, Alling DW & Zimmerman HJ, et al. A prospective trial with colchicine for primary biliary cirrhosis. N Engl J Med 1986; 315: 144854.
  • 10
    Warnes TW, Smith A, Lee FI, Haboubi NY, Johnson PJ & Hunt L. A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report. J Hepatol 1987; 5: 17.
  • 11
    Bodenheimer HC, Schaffner F & Pezzullo J. Evaluation of colchicine therapy in primary biliary cirrhosis. Gastroenterology 1988; 95: 1249.
  • 12
    Zifroni A & Schaffner F. Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy. Hepatology 1991; 14: 9903.
  • 13
    Vuoristo M, Farkkila M & Karvonen A-L, et al. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid. Gastroenterology 1995; 108: 14708.
  • 14
    Kaplan MM, Schmid C, Provenzale D, Sharma A, Dickstein G & McKusik A. A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis. Gastroenterology 1999; 117: 117380.
  • 15
    Ikeda T, Tozuka S & Nogushi O, et al. Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. A prospective randomized study. J Hepatol 1996; 24: 8894.
  • 16
    Poupon RE, Huet PM, Poupon R, Van Bonnand A-M, Nhieu JT & Zafrani ES. and the UDCA-PBC Study Group. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1996; 24: 1098103.
  • 17
    Shapiro JM, Smith H & Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut 1979; 20: 13740.
  • 18
    Dickson ER, Grambsch PM, Fleming TR, Fisher LD & Langworthy A. Prognosis in primary biliary cirrhosis: Model for decision making. Hepatology 1989; 10: 17.
  • 19
    Christensen E, Neuberger J & Crowe J, et al. Beneficial effects of azathioprine and prediction of prognosis in primary biliary cirrhosis. Gastroenterology 1985; 89: 108991.
  • 20
    Taal BG, Schalm SW, Ten Kate FWJ, Hermans J, Geertzen RGM & Feltkamp BEW. Clinical diagnosis of primary biliary cirrhosis based on major criteria. Hepatogastroenterology 1983; 30: 17882.
  • 21
    Ludwig J, Dickson ER & McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 1978; 379: 10312.
  • 22
    Angulo P, Dickson ER & Therneau TM, et al. Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial. J Hepatol 1999; 30: 8305.
  • 23
    Van Hoogstraten HJF, Desmet MBM & Renooij W, et al. A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. Aliment Pharmacol Ther 1998; 12: 96571.DOI: 10.1046/j.1365-2036.1998.00395.x
  • 24
    Verma A, Jazrawi RP & Ahmed HA, et al. Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 1999; 11: 106976.
  • 25
    Podda M, Ghezzi C & Battezzati PM, et al. Effect of different doses of ursodeoxycholic acid in chronic liver disease. Dig Dis Sci 1989; 34: 59S65S.
  • 26
    Vogel W, Katherine H, Judmaier G & Braunsteiner H. Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid. Lancet 1988; i: 11631163.
  • 27
    Perdigoto R & Wiesner RH. Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy. Gastroenterology 1992; 102: 138991.
  • 28
    Battezzati PM, Podda M & Bianchi FB, et al. Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. J Hepatol 1993; 17: 3328.
  • 29
    Poupon R, Poupon RE & Lebrec D, et al. Mechanisms for reduced hepatic clearance and elevated plasma levels of bile acids in cirrhosis. Gastroenterology 1981; 80: 143844.
  • 30
    Jazrawi RA, De Caestecker JS & Goggin PM, et al. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology 1994; 106: 13442.
  • 31
    Crosignani A, Setchell KDR, Invernizzi P, Larghi A, Rodrigues CMP & Podda M. Clinical pharmacokinetics of therapeutic bile acids. Clin Pharmacokinet 1996; 30: 33358.
  • 32
    Hoffman AF. Pharmacology of ursodeoxycholic acid an enterohepatic drug. Scand J Gastroenterol 1994; 29(Suppl. 204): 15.
  • 33
    Walker S, Stiehl A, Raedsch R, Kloters P & Kommerell B. Absorption of urso- and chenodeoxycholic acid and their taurine and glycine conjugates in rat jejunum ileum and colon. Digestion 1985; 32: 4752.